Work

Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk

Year: 2024

Type: article

Study design: Observational Study

Source: Pharmacoepidemiology and Drug Safety

DOI: 10.1002/pds.70040

Authors: Cheng Chen, Efe Eworuke, Ashish Rai, Laura Hou, Jenice S. Ko, Mary Ross Southworth, José J. Hernández‐Muñoz, Mingfeng Zhang

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, Harvard University, Harvard Pilgrim Health Care

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Food and Drug Administration, Food and Drug Administration

Awards: G1040074352, G2603347885, G7928494562, G8891628946

OpenAlex ID: W4403405431

FWCI: 3.055

Cites: 13

Cited by: 4

Related to: 10